Table 1 Correlation between GLI2 and clinicopathologic parameters in gastric cancer.

Characteristic		Expression of GLI2		X²-test	p value
Characteristic		High	Low	X²-test	p value
Gender	Male	47	26	0.017	0.502
Gender	Female	20	8	0.017	0.502
Age (years)	≤50	57	30	0.45	0.897
Age (years)	>50	10	4	0.45	0.897
Pathological	Intestinal	6	3	0.04	0.98
	Diffuse	54	27
	Signet ring	7	4
Differentiation	G1 G2	15	19	11.33	0.001
Differentiation	G3	52	15	11.33	0.001
Max tumor diameter	>5 cm	47	16	5.12	0.024
Max tumor diameter	≤5 cm	20	18	5.12	0.024
T classification	T1 T2	12	16	9.564	0.002
T classification	T3 T4	55	18	9.564	0.002
N classification	Positive	56	18	5.598	0.018
N classification	Negative	11	16	5.598	0.018
Clinical staging	I II	35	17	0.045	0.832
Clinical staging	III IV	32	17	0.045	0.832
Cisplatin therapy	Sensitive	9	21	4.344	0.037
Cisplatin therapy	Resistant	17	13	4.344	0.037

Quick links

Search